Evidence map›Paper›PMID 35746615›Full record

ReviewViruses2022

NK Cells in Protection from HIV Infection.

Nicole F Bernard, Khlood Alsulami, Erik Pavey, Franck P Dupuy

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nicole F BernardResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A3J1, Canada.ORCID 0000-0001-5311-9409
Khlood AlsulamiResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A3J1, Canada.
Erik PaveyResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A3J1, Canada.
Franck P DupuyResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A3J1, Canada.
McGill University Health Centre · CA

Funding

CIHR 142494CIHR 148491
6 · The paper itself

Abstract

Some people, known as HIV-exposed seronegative (HESN) individuals, remain uninfected despite high levels of exposure to HIV. Understanding the mechanisms underlying their apparent resistance to HIV infection may inform strategies designed to protect against HIV infection. Natural Killer (NK) cells are innate immune cells whose activation state depends on the integration of activating and inhibitory signals arising from cell surface receptors interacting with their ligands on neighboring cells. Inhibitory NK cell receptors use a subset of major histocompatibility (MHC) class I antigens as ligands. This interaction educates NK cells, priming them to respond to cells with reduced MHC class I antigen expression levels as occurs on HIV-infected cells. NK cells can interact with both autologous HIV-infected cells and allogeneic cells bearing MHC antigens seen as non self by educated NK cells. NK cells are rapidly activated upon interacting with HIV-infected or allogenic cells to elicit anti-viral activity that blocks HIV spread to new target cells, suppresses HIV replication, and kills HIV-infected cells before HIV reservoirs can be seeded and infection can be established. In this manuscript, we will review the epidemiological and functional evidence for a role for NK cells in protection from HIV infection.

Indexed as

HIV-1HIV InfectionsCD4-Positive T-LymphocytesHistocompatibility Antigens Class IHumansKiller Cells, NaturalLigandsHistocompatibility Antigens Class ILigandsHIVHIV-exposed seronegativeHLAHLA-B*57killer immunoglobulin-like receptorsnatural killer cells

Identifiers

PMID35746615
PMCPMC9231282
OpenAlexW4281833921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.